Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Collins

Showing results (141-150 of 247) with videos related to

Pageof 25
Sort By:
Cell Reports|August 16, 2018
Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine VectorsMichelle Meyer, Asuka Yoshida, Palaniappan Ramanathan, et al.
Journal of Virology|May 28, 2010
Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitroAnna R Kwilas, Mark A Yednak, Liqun Zhang, et al.
Journal of Virology|July 15, 2005
Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virusAlexander Bukreyev, Igor M Belyakov, Gregory A Prince, et al.
Journal of Virology|June 6, 2008
Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epitheliumEmmalene J Bartlett, Margaret Hennessey, Mario H Skiadopoulos, et al.
Virology|November 23, 2005
Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunityMario H Skiadopoulos, Stéphane Biacchesi, Ursula J Buchholz, et al.
Journal of Virology|October 18, 2005
Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primatesAlexander Bukreyev, Zhuhui Huang, Lijuan Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2007
Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogensJoshua M DiNapoli, Alexander Kotelkin, Lijuan Yang, et al.
Journal of Virology|May 30, 2006
The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopesAlexander Bukreyev, Maria Elina Serra, Federico R Laham, et al.
Biomarker Research|December 22, 2016
Development and validation of a novel bioassay to determine glucocorticoid sensitivityEmily L Williams, Madeleine L Stimpson, Peter L Collins, et al.
Journal of Virology|March 28, 2014
Human metapneumovirus SH and G glycoproteins inhibit macropinocytosis-mediated entry into human dendritic cells and reduce CD4+ T cell activationCyril Le Nouën, Philippa Hillyer, Linda G Brock, et al.
Pageof 25

Showing results (141-150 of 247) with videos related to

Sort By:
Pageof 25
Cell Reports|August 16, 2018
Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine VectorsMichelle Meyer, Asuka Yoshida, Palaniappan Ramanathan, et al.
Journal of Virology|May 28, 2010
Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitroAnna R Kwilas, Mark A Yednak, Liqun Zhang, et al.
Journal of Virology|July 15, 2005
Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virusAlexander Bukreyev, Igor M Belyakov, Gregory A Prince, et al.
Journal of Virology|June 6, 2008
Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epitheliumEmmalene J Bartlett, Margaret Hennessey, Mario H Skiadopoulos, et al.
Virology|November 23, 2005
Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunityMario H Skiadopoulos, Stéphane Biacchesi, Ursula J Buchholz, et al.
Journal of Virology|October 18, 2005
Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primatesAlexander Bukreyev, Zhuhui Huang, Lijuan Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2007
Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogensJoshua M DiNapoli, Alexander Kotelkin, Lijuan Yang, et al.
Journal of Virology|May 30, 2006
The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopesAlexander Bukreyev, Maria Elina Serra, Federico R Laham, et al.
Biomarker Research|December 22, 2016
Development and validation of a novel bioassay to determine glucocorticoid sensitivityEmily L Williams, Madeleine L Stimpson, Peter L Collins, et al.
Journal of Virology|March 28, 2014
Human metapneumovirus SH and G glycoproteins inhibit macropinocytosis-mediated entry into human dendritic cells and reduce CD4+ T cell activationCyril Le Nouën, Philippa Hillyer, Linda G Brock, et al.
Pageof 25